(19)
(11) EP 2 694 463 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
09.10.2019 Bulletin 2019/41

(45) Mention of the grant of the patent:
04.09.2019 Bulletin 2019/36

(21) Application number: 12767439.8

(22) Date of filing: 04.04.2012
(51) International Patent Classification (IPC): 
A61K 31/122(2006.01)
A61P 35/02(2006.01)
 A61P 35/00(2006.01)
(86) International application number:
PCT/US2012/032178
(87) International publication number:
WO 2012/138765 (11.10.2012 Gazette 2012/41)

(54)

TREATING CENTRAL NERVOUS SYSTEM TUMORS WITH COENZYME Q10

BEHANDLUNG VON TUMOREN IM ZENTRALNERVENSYSTEM MIT COENZYM Q10

TRAITEMENT DE TUMEURS DU SYSTÈME NERVEUX CENTRAL AVEC COENZYME Q10

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 04.04.2011 US 201161471659 P

(43) Date of publication of application:
12.02.2014 Bulletin 2014/07

(73) Proprietor: Berg LLC
Framingham, MA 01701 (US)

(72) Inventors:
  • JIMENEZ, Joaquin, J.
    Miami, FL 33144 (US)
  • NARAIN, Niven, Rajin
    Cambridge, MA 02138 (US)
  • SARANGARAJAN, Rangaprasad
    Boylston, MA 01505 (US)
  • MCCOOK, John, Patrick
    Frisco, TX 75034 (US)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)


(56) References cited: : 
EP-A1- 1 908 459
WO-A2-2011/112900
US-A1- 2009 005 398
US-A1- 2011 027 247
 WO-A2-2005/069916
US-A1- 2008 287 541
US-A1- 2010 209 388
   
  • 'Fact Sheet: Brain Tumor' LOS ANGELES CAREGIVER RESOURCE CENTER, [Online] 2004, pages 1 - 12, XP008172098 Retrieved from the Internet: <URL:http://lacrc.usc.edu/forms/brain tumor.pdf> [retrieved on 2012-06-19]
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).